Increased expression of gelatinase (MMP-2 and MMP 9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 10, 2009, Pages 4588-4596

  Yang, Shun Fa ^a,b   Lin, Ching Yang ^c   Yang, Pei Yu ^d   Chao, Shih Chun ^c   Ye, Yi Zhen ^d   Hu, Dan Ning ^d,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Department of Ophthalmology ^*  (Taiwan)

^d SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^e NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; MESSENGER RNA; MMP2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY; CONJUNCTIVA; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELLS, CULTURED; CONJUNCTIVA; DISEASE PROGRESSION; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROTEIN KINASE C; PTERYGIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

EID: 70349582730     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3147     Document Type: Article

References (45)

1. Coroneo MT. Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol. 1993;77:734-739.
2. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999;10:282-288.
3. Hilgers JHC. Pterygium: its incidence, heredity and etiology. Am J Ophthalmol. 1960;50:635-644.
4. Karai I, Horiguchi S. Pterygium in welders. Br J Ophthalmol. 1984;68:347-349.
5. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol. 1999;128:280-287.
6. Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf. 2008 6:24-43.
7. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol. 2001;119:695-706.
8. Li D, Lee S, Gunja-Smith Z, et al. Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol. 2001;119:71-80.
9. Solomon A, Li D, Lee S, Tseng SCG. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci. 2000;41:2154-2163.
10. Chen JK, Tsai RJ, Lin SS. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol Anim. 1994;30:243-248.
11. Kria K, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 1998;236:702-708.
12. Yong VW, Krekoski CA, Forsyth PA, Bell, Edwards D. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998;21:75-80.
13. Kahari V, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999;31:34-45.
14. Westermarck J, Kahari V. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999;13:781-792.
15. Romantic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 1994;4:146-156.
16. Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS. 1999;107:38-44.
17. Di Girolamo N, Coroneo MT, Wakefield D. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK 1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci. 2003;44:4705-4714.
18. Zeng J, Jiang D, Liu X, Tang L. Expression of matrix metalloproteinase in human pterygia. Yan Ke Xue Bao. 2004;20:242-245.
19. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci. 2000;41: 4142-4149.
20. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci. 2001;42:1963-1968.
21. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors and matrix metalloproteinases. Prog Retin Eye Res. 2004;23:195-228.
22. Di Girolamo N, Coroneo MT, Wakefield D. Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol. 2005;167:489-503.
23. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41: 671-679.
24. Aimes RT, Quigley JP. Matrix metalloproteinase is an interstitial collagenase. J Biol Chem. 1995;270:5872-5876.
25. Okada Y, Naka K, Kawamura K, et al. Localization of matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase-gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest. 1995;72:311-322.
26. Basset P, Okada A, Chenard MP, et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 1997;15:535-541.
27. Murphy G, Knauper V. Relating matrix metalloproteinase structure to function: why the 'hemopexin' domain? Matrix Biol. 1997;15: 511-518.
28. Ryter SW, Kim HP, Hoetzel A, Park J, Nakahira K, Wang X, Choi A. Mechanisms of cell death in oxidative states. Antioxid Redox Signal. 2007;9:49-89.
29. He YY, Huang JL, Chingnell CF. Delayed and sustained activation of extracellular signal-regulated kinase in human keratinocytes by UVA: implications in carcinogenesis. J Biol Chem. 2004;279: 53867-53874.
30. Sodhi A, Sethi G. Role of protein kinase C delta in UV-B-induced apoptosis of macrophages in vitro. Cell Signal. 2005;17:377-383.
31. Li D-Q, Tseng SCG. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61-79.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976;72:248-254.
33. Chu SC, Hu DN, Yang SF, et al. Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro. Pigment Cell Res. 2004;17: 636-642.
34. Wang PH, Ko JL, Tsai HT, et al. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array. Gynecol Oncol. 2008;108:533-542.
35. Weng CJ, Chau CF, Hsieh YS, Yang SF, Yen GC. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-k{cyrillic}B and AP-1. Carcinogenesis. 2008;29: 147-156.
36. Fini ME, Girard MT. The pattern of metalloproteinase expression by corneal fibroblasts is altered by passage in cell culture. J Cell Sci. 1990;97:373-383.
37. Di Girolamo N, Lloyd A, McCluskey P, Coroneo MT, Wakefield D. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol. 1997;150:653-666.
38. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol. 1996;3:895-904.
39. Foda HD, George S, Conner C, Drews M, Tompkins DC, Zucker S. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate. Lab Invest. 1996;74:538-545.
40. Lee WJ, Shin CY, Yoo BK, et al. Induction of matrix metalloproteinases-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia. 2003;41:15-24.
41. Park MJ, Park IC, Hur JH, et al. Modulation of phorbol esterinduced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase. J Neurosurg. 2002;97:112-118.
42. Liu JF, Crepin M, Liu JM, Barritaulth D, Ledoux D. FGF-2 and TPA induce matrix metalloproteinases-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun. 2002;17:1174-1182.
43. da Rocha AB, Mans DR, Lenz G, et al. Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signalregulated kinase and ornithine decarboxylase. Pathobiology. 2000;68:113-123.
44. Shearer T, Crosson CE. Activation of extracellular signal-regulated kinase in trabecular meshwork cells. Exp Eye Res. 2001;73:25-35.
45. Fini ME, Girard MT, Matsubara M, Bartlett JD. Unique regulation of the matrix metalloproteinase, gelatinase B. Invest Ophthalmol Vis Sci. 1995;36:622-633.